Safety of human albumin—serious adverse events reported worldwide in 1998–2000 † †Declaration of interest. This investigation was supported by an unrestricted grant from the Plasma Protein Therapeutics Association. The sponsor played no role in the analysis and interpretation of data or the preparation and submission of the manuscript. Hygeia Associates is an independent organization specializing in the statistical analysis of biomedical research data and is in no way affiliated with the sponsor, either directly or indirectly. None of the co-investigators in this study has any conflict of interest to declare.
Author:
Publisher
Elsevier BV
Subject
Anesthesiology and Pain Medicine
Link
http://academic.oup.com/bja/article-pdf/91/5/625/703538/aeg233.pdf
Reference36 articles.
1. Safety of human albumin based on spontaneously reported serious adverse events;von Hoegen;Crit Care Med,2001
2. Pharmacovigilance in the pharmaceutical industry;Talbot;Br J Clin Pharmacol,1998
3. Spontaneous reporting of adverse drug reactions. I: the data;Rawlins;Br J Clin Pharmacol,1988
4. Human albumin administration in critically ill patients: systematic review of randomised controlled trials;Cochrane Injuries Group Albumin Reviewers;Br Med J,1998
5. Human albumin—where are we now?;Rennie;Br J Intens Care,1998
Cited by 86 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Geriatric patients with acute kidney injury in the intensive care unit: the effect of vitamin B12 and albumin levels on survival;The European Research Journal;2024-08-28
2. European Society of Intensive Care Medicine clinical practice guideline on fluid therapy in adult critically ill patients. Part 1: the choice of resuscitation fluids;Intensive Care Medicine;2024-05-21
3. Complexing Protein-Free Botulinum Neurotoxin A Formulations: Implications of Excipients for Immunogenicity;Toxins;2024-02-10
4. Identifying new safety risk of human serum albumin: a retrospective study of real-world data;Frontiers in Pharmacology;2024-01-15
5. Human Serum Albumin (HSA) as a Stabilizer in Aesthetic Injectables;Toxicon;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3